Publications by authors named "Francois Lamoureux"

47Publications

Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.

Cancers (Basel) 2021 Feb 8;13(4). Epub 2021 Feb 8.

UMR1238, Phy-OS, Sarcomes Osseux et Remodelage des Tissus Calcifiés, INSERM, Université de Nantes, 44035 Nantes, France.

View Article and Find Full Text PDF
February 2021

Development of prohibitin ligands against osteoporosis.

Eur J Med Chem 2021 Jan 23;210:112961. Epub 2020 Oct 23.

Laboratory of Regenerative Nanomedicine (RNM), INSERM U 1260, CRBS, Rue Eugène Boeckel, 67000, Strasbourg, France; Sino-French Joint Lab of Food Nutrition/Safety and Medicinal Chemistry, College of Biotechnology, Tianjin University of Science and Technology, Tianjin, China. Electronic address:

View Article and Find Full Text PDF
January 2021

Ribosomopathies: New Therapeutic Perspectives.

Cells 2020 09 11;9(9). Epub 2020 Sep 11.

INSERM, Bone sarcomas and remodeling of calcified tissues, Nantes Université, UMR 1238, F-44000 Nantes, France.

View Article and Find Full Text PDF
September 2020

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model.

EBioMedicine 2020 Mar 7;53:102704. Epub 2020 Mar 7.

Université de Nantes, INSERM, U1238, Sarcomes osseux et remodelage des tissus calcifiés, Team 3, Epistress, Rue Gaston Veil, 44035 Nantes cedex, France. Electronic address:

View Article and Find Full Text PDF
March 2020

BET bromodomains' functions in bone-related pathologies.

Epigenomics 2020 01 18;12(2):127-144. Epub 2019 Dec 18.

Nantes Université, INSERM, Bone sarcomas & remodeling of calcified tissues, UMR 1238, F-44000 Nantes, France.

View Article and Find Full Text PDF
January 2020

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice.

EBioMedicine 2019 Jun 29;44:452-466. Epub 2019 May 29.

Department of Oncology and Metabolism, University of Sheffield, Medical School, Beech Hill Road, Sheffield S10 2RX, UK; Bone and Cancer Group, Edinburgh Cancer Research Centre, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, EH4 2XR, UK. Electronic address:

View Article and Find Full Text PDF
June 2019

Analysis of mRNA, miRNA, and DNA in Bone Cells by RT-qPCR and In Situ Hybridization.

Methods Mol Biol 2019 ;1914:169-196

INSERM, UMR1238, Bone Sarcoma and Remodeling of Calcified Tissues, Université de Nantes, Nantes Atlantique Universités, Nantes, France.

View Article and Find Full Text PDF
June 2019

Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification.

PLoS One 2018 26;13(1):e0191976. Epub 2018 Jan 26.

INSERM, UMR 1238, Nantes, France; Université de Nantes, Nantes Atlantique Universités, Laboratoire « Sarcome osseux et remodelage des tissus osseux calcifiés », Faculté de Médecine, Nantes, France.

View Article and Find Full Text PDF
March 2018

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.

Int J Mol Sci 2016 Dec 20;17(12). Epub 2016 Dec 20.

Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 957, Pathophysiology of Bone Resorption and Therapy of Primary Bone Tumours, Equipe Ligue 2012, Faculty of Medicine, University of Nantes, Nantes 44035, France.

View Article and Find Full Text PDF
December 2016

Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis.

Bone 2017 01 23;94:10-21. Epub 2016 Sep 23.

INSERM, UMR 957, équipe labellisée ligue 2012, 1 Rue Gaston Veil, 44035 Nantes, France; Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes Atlantique Universités, EA3822, 1 Rue Gaston Veil, 44035 Nantes, France. Electronic address:

View Article and Find Full Text PDF
January 2017

ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis.

Cancer Res 2016 06 17;76(11):3236-51. Epub 2016 Mar 17.

INSERM, UMR-S 957, Nantes, Equipe labellisée LIGUE 2012, France. Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Université de Nantes, Nantes Atlantique Universités, Rue Gaston Veil, Nantes, France.

View Article and Find Full Text PDF
June 2016

Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression.

Clin Cancer Res 2016 05 28;22(10):2520-33. Epub 2015 Dec 28.

Université de Nantes, Nantes atlantique universités, Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes, France. INSERM, UMR 957, Nantes, France. LUNAM Université, Nantes, France. Equipe labellisée LIGUE 2012, Nantes, France.

View Article and Find Full Text PDF
May 2016

Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcoma.

Oncotarget 2014 Sep;5(17):7805-19

Université de Nantes, Nantes atlantique universités, Laboratoire de Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes F-44035, France. INSERM, UMR 957, Nantes F-44035, France. LUNAM Université. Equipe labellisée LIGUE 2012, Nantes, cedex.

View Article and Find Full Text PDF
September 2014